PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.08

-2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John F. Dowd who wrote (5852)	10/8/1998 12:43:00 AM
From: Anthony Wong	Read Replies (2) of 9523

John, I am quite confident that PFE's next earnings report will surprize the Street. In their first half earnings report of 1998 they reported double digit growth in many of their drugs - Norvasc for hypertension, Zoloft for depression, Zyrtec for allergies and Zithromax (antibiotic). Trovan received European approval in July of this year so sales from Europe would be added to this quarter's revenues. Lipitor continues to gain market share (PFE's share was 350 million in the first half, so it's at least 700 million revenue per year). Even if Viagra sales disappoint, it would be more than made up by increased revenues from the other blockbusters. The correction is almost over, and it's time to buy for those who missed the boat last time. Anthony

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next